Axsome Therapeutics, Inc. (AXSM)
163.90
-2.48
(-1.49%)
USD |
NASDAQ |
Mar 03, 15:51
Axsome Therapeutics Total Liabilities (Quarterly) : 601.51M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 190.22M |
| Gilead Sciences, Inc. | 36.40B |
| Vanda Pharmaceuticals, Inc. | 161.76M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Amicus Therapeutics, Inc. | 675.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 689.80M |
| Shareholders Equity (Quarterly) | 88.30M |
| Debt to Equity Ratio | 2.470 |
| Current Ratio | 1.555 |
| Net Debt Paydown Yield | -0.06% |